Cargando…
Inhaled corticosteroids in COPD: Personalising the therapeutic choice
There has been a recent surge in interest in the role of inhaled corticosteroids (ICS) in the treatment of COPD, especially regarding patients with high eosinophil counts. Evidence has shown that despite the increase in localised adverse effects and a small increase in non-fatal pneumonia events wit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
South African Medical Association
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432921/ https://www.ncbi.nlm.nih.gov/pubmed/34541493 http://dx.doi.org/10.7196/AJTCCM.2018.v24i1.184 |